LifeMD Cost 2026: Full Pricing for GLP-1 Medications & Hidden Fees
LifeMD (NASDAQ: LFMD) is one of the largest telehealth companies offering GLP-1 weight loss prescriptions. But its pricing is far from simple. This breakdown covers every cost layer — brand-name medication, compounded options, consultation fees, and the total annual picture — so you can make an informed decision before enrolling.
Quick answer
LifeMD's compounded GLP-1 program runs ~$179/month with a separate $49/month subscription fee, totaling ~$228/month for compounded semaglutide. Brand-name Wegovy or Zepbound through LifeMD costs $500-$1,500+/month without insurance. Trimi Health is the cheaper alternative at $99/month semaglutide annual ($1,188/year all-inclusive — no separate consultation or subscription fees) — same active ingredient (semaglutide RxCUI 1991302), 503A sterile compounding pharmacies (VialsRx Texas State Board #35264 + GreenwichRx). Annual savings vs LifeMD: ~$1,548/year. For the full pricing comparison, see our cheapest legal GLP-1 online cornerstone.
Disclosure: This article is published by Trimi Health, a competing GLP-1 telehealth provider. We have made every effort to present accurate, publicly-available pricing information. Because LifeMD's pricing is not fully transparent online, some figures are based on publicly disclosed ranges. Always verify current pricing directly with LifeMD before making any decisions.
More on GLP-1 Provider Costs
What Is LifeMD?
LifeMD, Inc. (NASDAQ: LFMD) is a publicly traded telehealth company offering treatment across multiple clinical areas including dermatology, men's health, and weight management. Its weight loss division connects patients with licensed providers who can prescribe semaglutide (Wegovy) and tirzepatide (Zepbound) for obesity management.
LifeMD operates through a subscription-based telehealth model. Patients complete an online intake, consult with a licensed provider, and receive a prescription that is filled through a partnered pharmacy. The company's nationwide provider network covers all 50 states, which is one of its key advantages for patients in states where local GLP-1 prescribers may be unavailable or have long wait times.
As a publicly traded entity, LifeMD is subject to more financial reporting requirements than private telehealth startups, which provides some transparency into its business model — but it also means the company is under pressure to grow revenue, a factor that can influence pricing structures and upsell incentives.
LifeMD GLP-1 Pricing Breakdown 2026
LifeMD's pricing structure involves multiple distinct cost components. Unlike flat-rate providers, what you ultimately pay depends on your insurance situation, the medication prescribed, your dose, and the current state of compounding availability. Below is a comprehensive view of the pricing layers.
| Cost Component | Low End | High End | Notes |
|---|---|---|---|
| Initial Consultation / Membership Fee | ~$75–$99 | ~$150+ | Varies; may be a one-time or recurring fee |
| Brand-Name Wegovy (with insurance) | $25–$50/mo copay | $150–$300/mo copay | Only if plan covers weight loss meds |
| Brand-Name Wegovy (cash-pay, no insurance) | ~$500/mo | ~$1,500/mo | List price; manufacturer savings cards may reduce |
| Brand-Name Zepbound (cash-pay, no insurance) | ~$550/mo | ~$1,500/mo | Eli Lilly vials may be lower; pen auto-injectors higher |
| Compounded Semaglutide (if available) | ~$150/mo | ~$350/mo | Subject to regulatory changes; confirm current availability |
| Ongoing Provider Follow-Ups | Included in some plans | $50–$100/visit extra | Varies by plan tier and frequency |
| Lab Work (if required) | $0 (if in-network) | $100–$300 | Metabolic panels may be ordered prior to starting |
| Trimi All-Inclusive (for comparison) | $99/mo | $99/mo | Flat rate; includes medication, consult, ongoing care |
Prices are approximate based on publicly available information as of April 2026. LifeMD's pricing may change; verify directly with LifeMD for current rates.
Annual Cost Projections: What You Really Spend
The monthly sticker price on any GLP-1 program understates the true annual burden. GLP-1 medications are typically intended as long-term treatments — most guidelines recommend continued use to maintain weight loss, meaning patients who start treatment are looking at multi-year, not single-month, commitments. Here is what a full year looks like across different LifeMD scenarios compared to Trimi.
| Scenario | Monthly Cost | Year 1 Total | Year 2 Total |
|---|---|---|---|
| LifeMD — Brand-name, no insurance | $500–$1,500 | $6,150–$18,150* | $6,000–$18,000 |
| LifeMD — Brand-name, with insurance copay | $25–$300 | $450–$3,750* | $300–$3,600 |
| LifeMD — Compounded semaglutide (if available) | $150–$350 | $1,950–$4,350* | $1,800–$4,200 |
| Trimi — All-inclusive flat rate | $99 | $1,188 | $1,188 |
*Year 1 totals include estimated one-time consultation fee. Annual figures are approximate. Verify with LifeMD for current pricing.
Over two years of treatment — which is not unusual given that GLP-1 maintenance is typically ongoing — the cost difference between LifeMD on brand-name medication without insurance and Trimi's flat rate can exceed $30,000. Even in a favorable insurance scenario, LifeMD patients may still pay two to three times what Trimi patients pay annually.
Hidden Fees and Costs to Watch For
Beyond the headline medication price, several secondary costs can add up substantially over the course of treatment. These are the fees that patients frequently report not anticipating when they initially enrolled.
Consultation / Platform Membership Fees
LifeMD charges for access to its provider platform. These fees may be structured as a one-time onboarding fee, a recurring monthly membership, or both. They are separate from medication costs and are generally not covered by insurance.
Dose Escalation Cost Increases
GLP-1 medications are titrated upward over time. Higher doses — which most patients eventually reach — cost more per month than starting doses. Your month-one cost is often the lowest you will ever pay. Budget for escalating costs as your dose increases through the standard titration schedule.
Insurance Prior Authorization Hurdles
Even if your insurance plan technically covers GLP-1 medications, you may face a multi-week prior authorization process, step therapy requirements (proving you tried other medications first), or repeated approval renewals. During any gap in insurance coverage — which can happen at policy renewal — you may face full cash-pay prices temporarily.
Lab Work and Monitoring Tests
Some providers require baseline metabolic panels, thyroid function tests, or HbA1c measurements before prescribing GLP-1 medications. If your insurance does not cover these or you are uninsured, lab costs can add $100 to $300 upfront.
Supply Chain Disruptions
Brand-name semaglutide shortages have been well-documented. If your prescribed dose is unavailable, you may face delays, dose substitutions, or pressure to switch to more expensive alternatives. Compounded semaglutide availability through LifeMD also depends on regulatory status, which has been in flux as the FDA reconsiders compounding rules.
Manufacturer Savings Cards — Not Always Applicable
Novo Nordisk's Wegovy savings card can reduce brand-name costs substantially, but only applies to commercially insured patients who meet eligibility criteria. Medicare and Medicaid patients are excluded. If your insurance does not cover Wegovy, you may be ineligible for the savings card entirely, leaving you at full cash-pay price.
Brand-Name vs. Compounded Semaglutide Through LifeMD
The single biggest cost driver in LifeMD's pricing is whether you receive brand-name Wegovy/Zepbound or a compounded version. The difference can be $300 to $1,200 per month — a 3x to 10x cost multiplier.
Brand-name semaglutide (Wegovy) is FDA-approved specifically for chronic weight management. It has been tested in large-scale clinical trials, including the landmark STEP 1 trial demonstrating ~15% average body weight reduction over 68 weeks. The brand-name product offers dose-calibrated pens, a well-established safety profile, and direct manufacturer support programs.
Compounded semaglutide contains the same active ingredient but is prepared by compounding pharmacies rather than by Novo Nordisk. During periods when Wegovy has been on the FDA shortage list, compounding has been legally permitted as an alternative. As shortage designations are lifted, the legal landscape for compounded GLP-1 products tightens. LifeMD — as a publicly traded, compliance-oriented company — has generally followed FDA guidance on compounding availability, meaning compounded options may not always be accessible through their platform.
Confirm Compounding Availability
LifeMD's compounded semaglutide availability changes with FDA regulatory guidance. Before assuming compounded options are available, confirm directly with LifeMD. If compounding has been restricted by the time you are reading this, you may only have access to brand-name pricing, which is substantially higher.
When LifeMD Makes Sense vs. When Trimi Is Better
LifeMD and Trimi serve overlapping patient populations but are structured differently. The right choice depends on your insurance situation, preferences, and what you specifically need from a GLP-1 program.
LifeMD May Be the Better Fit If…
You have insurance that covers brand-name Wegovy or Zepbound and need help navigating prior authorization — LifeMD has infrastructure for this.
You specifically require brand-name medication with Novo Nordisk or Eli Lilly manufacturer support and savings programs.
You want a publicly traded, established company with a track record and public financial accountability.
You have tried compounded options and prefer brand-name for consistent dosing precision and packaging.
Your employer benefit plan has a specific partnership with LifeMD or a related platform.
Trimi Is Likely the Better Fit If…
You are paying out of pocket and want the lowest all-inclusive monthly cost — Trimi's flat $99/month includes medication, consultations, and ongoing care.
You want price predictability with no hidden fees, dose-based cost increases, or insurance uncertainty.
Your insurance does not cover GLP-1 medications for weight loss, which is still the case for many plans.
You want the flexibility to cancel anytime without financial penalties or annual contract commitments.
You want a program focused exclusively on GLP-1 weight management rather than a multi-condition telehealth platform.
For the majority of patients paying out of pocket — the most common situation given inconsistent insurance coverage — see also our cheapest legal GLP-1 online cornerstone for the full pricing comparison across all major providers — the cost difference between LifeMD on brand-name medication and Trimi is substantial enough to be financially disqualifying. A patient paying $700/month through LifeMD versus $99/month through Trimi is spending $7,212 more per year for the same therapeutic outcome: reduced appetite, weight loss driven by GLP-1 receptor agonism.
The medication works through identical mechanisms regardless of who prescribes it. When comparing providers, it is worth asking: what additional value does the higher-priced option provide? For some patients with strong insurance and a need for brand-name medication, LifeMD provides real value. For the cash-pay majority, the extra cost is difficult to justify.
LifeMD vs. Trimi: Direct Cost Comparison
To make the comparison concrete, here is a side-by-side view of LifeMD and Trimi across the most important dimensions for cost-focused patients evaluating compounded GLP-1 providers.
| Factor | LifeMD | Trimi |
|---|---|---|
| Monthly cost (cash-pay) | $150–$1,500+ | $99 flat |
| Annual cost (cash-pay, year 1) | $1,950–$18,150+ | $1,188 |
| Consultation fee | Separate charge may apply | Included |
| Medication included in price | No — billed separately | Yes |
| Follow-up visits | May cost extra | Included |
| Price predictability | Variable — dose & insurance dependent | Fixed flat rate |
| Cancel anytime | Yes | Yes |
| Compounded semaglutide | Availability varies | Yes |
| Tirzepatide available | Yes (brand-name) | Yes (compounded) |
| Insurance navigation | Yes | Limited |
| Brand-name option | Yes (Wegovy, Zepbound) | Not primary offering |
If you are reading this while evaluating whether LifeMD's costs are worth it, the most important question to answer first is whether you have insurance coverage. That single variable changes the math dramatically. If you do not have coverage — and many people do not — the most affordable path to GLP-1 therapy runs through flat-rate compounded programs, not brand-name platforms.
Navigating Insurance for LifeMD's Brand-Name Medications
If you are considering LifeMD specifically because you believe insurance will cover your medication, here are the critical steps to take before enrolling.
Call your insurance company directly and ask: 'Does my plan cover Wegovy (semaglutide) or Zepbound (tirzepatide) for chronic weight management?' Get the answer in writing or obtain a reference number.
Ask about prior authorization requirements. Many plans require documentation of a BMI above 30 (or 27+ with a weight-related comorbidity), a recorded attempt at lifestyle intervention, and provider attestation of medical necessity.
Ask whether step therapy is required — meaning you must fail on other medications before the plan approves a GLP-1.
Ask about your specific copay at each dose level. Some plans have tiered copays where higher doses cost more.
Ask whether the Novo Nordisk NovoCare savings card or Eli Lilly's savings program is compatible with your plan. These cards often cannot be used by patients with government insurance.
Confirm your plan's specialty drug tier and out-of-pocket maximum. GLP-1 medications are often on the highest specialty tier.
If insurance does cover your medication and you need prior authorization support, LifeMD's infrastructure for navigating that process is a genuine advantage. For patients whose plans do not cover GLP-1s for weight loss — which remains common despite the overall trend toward expanded coverage — LifeMD's brand-name pricing makes the program financially inaccessible for most people.
If You Are Appealing an Insurance Denial
A denial is not always final. See our guide on appealing insurance denials for GLP-1 medications for step-by-step instructions. Many initial denials are overturned on first appeal with proper documentation.
Frequently Asked Questions
How much does LifeMD cost per month in 2026?
LifeMD's monthly cost varies significantly depending on what you are prescribed. If you have insurance coverage for brand-name Wegovy or Zepbound, your out-of-pocket may range from $25 to $150 per month with a copay, but without insurance coverage, brand-name GLP-1 medications can cost $500 to $1,500 or more per month. LifeMD also offers compounded semaglutide options at lower price points, though pricing is not publicly listed and must be confirmed during consultation. Initial consultation fees may apply separately.
Does LifeMD accept insurance for GLP-1 medications?
LifeMD works with patients to navigate insurance coverage for brand-name GLP-1 medications like Wegovy and Zepbound. However, whether your specific plan covers these medications depends entirely on your insurer and plan design. Many commercial plans have begun covering GLP-1s for obesity, but prior authorization requirements, step therapy protocols, and employer-specific exclusions mean coverage is not guaranteed. LifeMD can help with prior authorization paperwork, but approval is ultimately the insurer's decision.
Does LifeMD offer compounded semaglutide?
LifeMD has offered compounded semaglutide as an option when brand-name products face supply shortages or when patients are unable to afford brand-name versions. As a publicly traded company (NASDAQ: LFMD), LifeMD's product offerings evolve with regulatory guidance. The FDA's changing stance on compounding availability means compounded GLP-1 availability through LifeMD may shift. Confirm current compounded options and pricing directly with LifeMD during your consultation.
What is LifeMD's consultation fee?
LifeMD charges an initial consultation or membership fee that covers access to a licensed provider who evaluates your eligibility for GLP-1 therapy. Consultation fee structures can change, and LifeMD has used different models including subscription-based access fees. These fees are separate from medication costs and are typically not covered by insurance. Confirm the current consultation and membership fee directly with LifeMD before starting.
What is the total annual cost of LifeMD without insurance?
Without insurance, the annual cost of LifeMD on brand-name GLP-1 therapy is among the highest in the market — potentially $6,000 to $18,000 per year for the medication alone, plus consultation fees. Compounded semaglutide options through LifeMD lower the cost, but pricing must be confirmed directly with the provider. By comparison, Trimi's flat $99/month all-inclusive semaglutide program costs $1,188 for a full year with no hidden fees.
Is LifeMD a legitimate company?
Yes, LifeMD is a legitimate publicly traded telehealth company listed on NASDAQ under the ticker symbol LFMD. It operates licensed telehealth providers across multiple states and works with licensed pharmacy partners. LifeMD's Weight Management division (formerly known as ShapiroMD) focuses on prescription weight loss. Being publicly traded adds a layer of financial transparency and regulatory scrutiny compared to private startups.
How does LifeMD compare to Trimi for cost?
LifeMD's costs are significantly higher than Trimi's for most patients. On cash-pay brand-name medication, LifeMD can cost $500 to $1,500 per month for the drug alone. Trimi's all-inclusive compounded semaglutide program is $99 per month — including medication, provider consultations, and ongoing care. Even if LifeMD offers compounded options, the consultation fees and variable pricing make cost comparison difficult without a direct quote. For cost-conscious patients without strong insurance, Trimi offers substantially better value.
Do I get the same clinical outcomes paying $99/month at Trimi versus $1,500/month at LifeMD for brand Wegovy?
Yes — the semaglutide molecule is identical regardless of source, so therapeutic outcomes match the established trial data. The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021; NCT03548935) demonstrated semaglutide 2.4 mg weekly produced a mean 14.9% body-weight reduction over 68 weeks in 1,961 adults; 86.4% achieved ≥5% weight loss and 50.5% achieved ≥15%. The SELECT trial (Lincoff et al., New England Journal of Medicine, 2023) confirmed a 20% reduction in major adverse cardiovascular events (hazard ratio 0.80; 95% CI 0.72-0.90; p<0.001) over 39.8 months mean follow-up in 17,604 adults. These outcomes are tied to the molecule and dose — not to brand-name versus compounded source. Compounded semaglutide from 503A-licensed pharmacies (like Trimi's partners VialsRx and GreenwichRx) uses the same active pharmaceutical ingredient as Wegovy from FDA-registered API suppliers.
Does LifeMD's brand-name Wegovy work better than Trimi's compounded semaglutide?
There is no published evidence that brand-name Wegovy produces different clinical outcomes than appropriately compounded semaglutide at equivalent doses, because both contain identical active pharmaceutical ingredient (semaglutide, RxCUI 1991302). What differs is: (1) Brand Wegovy is FDA-approved as a finished drug product, dispensed in pre-filled pens with single-use needle assemblies; (2) Compounded semaglutide is produced under FDA Section 503A by state-licensed pharmacies, typically dispensed as multi-dose vials drawn into provided syringes. Both pathways are legal. Clinical outcomes published in STEP 1 (NEJM 2021), STEP 5 (NEJM 2022), and SELECT (NEJM 2023) apply to the molecule itself. The relevant clinical differences between brand and compounded forms are in delivery method (pen vs vial) and dose precision considerations — not therapeutic efficacy.
What weight loss should I realistically expect on LifeMD's GLP-1 program vs Trimi?
Expected weight loss is determined by the medication and dose, not the provider. For semaglutide 2.4 mg weekly: mean 14.9% body-weight reduction over 68 weeks per STEP 1 (Wilding et al., NEJM 2021). For tirzepatide 15 mg weekly: mean 20.9% body-weight reduction over 72 weeks per SURMOUNT-1 (Jastreboff et al., NEJM 2022). 89.4% of SURMOUNT-1 participants on tirzepatide 15 mg achieved ≥5% weight loss; 56.7% achieved ≥20%. SURPASS-2 (Frias et al., NEJM 2021) directly compared tirzepatide to semaglutide in 1,879 patients with type 2 diabetes — tirzepatide 15 mg produced significantly greater weight reduction than semaglutide 1 mg (-11.2 kg vs -5.7 kg). Whether you receive these molecules through LifeMD, Trimi, or another platform with appropriate dose titration, the published outcome ranges apply equally to compounded and brand-name formulations.
Looking for a Predictable, Affordable Alternative?
Trimi offers compounded semaglutide for $99/month, all-inclusive — medication, provider consultations, dose adjustments, and ongoing support. No hidden fees, no annual contracts, cancel anytime.
Sources & References
- LifeMD, Inc. (NASDAQ: LFMD). Investor Relations and Corporate Overview. 2026. ir.lifemd.com
- Wilding JPH, Batterham RL, Calanna S, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)." New England Journal of Medicine. 2021;384(11):989-1002. NEJM | PubMed
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. "Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)." New England Journal of Medicine. 2022;387(3):205-216. NEJM | PubMed
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT)." New England Journal of Medicine. 2023;389(24):2221-2232. NEJM
- Frias JP, Davies MJ, Rosenstock J, et al. "Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2)." New England Journal of Medicine. 2021;385(6):503-515. NEJM
- FDA. Human Drug Compounding: Questions and Answers. fda.gov
- Section 503A of the Federal Food, Drug, and Cosmetic Act. 21 U.S.C. § 353a. Compounding by a Licensed Pharmacist.
- Kaiser Family Foundation. "Insurance Coverage of GLP-1 Weight Loss Drugs." KFF, 2025. kff.org
- Novo Nordisk. Wegovy (semaglutide) Prescribing Information and NovoCare Savings Program. 2025.
- Eli Lilly. Zepbound (tirzepatide) Prescribing Information and Savings Card Terms. 2025.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. GLP-1 medications require a prescription and medical evaluation from a licensed healthcare provider. Pricing information is based on publicly available data and may change. Trimi is a competing provider and this comparison is presented fairly, but readers should verify current LifeMD pricing directly at lifemd.com. Insurance coverage and eligibility vary by plan.